carbazilquinone has been researched along with Granulocytic Leukemia in 4 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Uzuka, Y | 1 |
Saito, Y | 1 |
Takahashi, H | 1 |
Komatsu, M | 1 |
Higuchi, T | 1 |
Okada, S | 1 |
Mori, H | 1 |
Niikura, H | 1 |
Omine, M | 1 |
Terada, H | 1 |
Wakabayashi, Y | 1 |
Takaku, F | 1 |
Yonekura, S | 1 |
Nagao, T | 1 |
Arimori, S | 1 |
4 other studies available for carbazilquinone and Granulocytic Leukemia
Article | Year |
---|---|
Carboquone therapy for hematologic neoplasms.
Topics: Administration, Oral; Adult; Aged; Azirines; Carbazilquinone; Female; Humans; Leukemia, Myeloid; Lym | 1982 |
Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent.
Topics: Adult; Aged; Carbazilquinone; Chromosome Aberrations; Female; Follow-Up Studies; Humans; Leukemia, M | 1995 |
[Studies of carboquone therapy on chronic myelogenous leukemia (author's transl)].
Topics: Adult; Azirines; Carbazilquinone; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Male; Middle A | 1978 |
Essential thrombocythemia developing into refractory anemia and complicated by acute myeloid leukemia.
Topics: Aged; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytarabin | 1992 |